At the news
? NEUTRALIMPACT 3/10 6-K filed Jun 12, 2026 at 06:00 ET
Evaxion announced it received the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology platform. This is a non-financial, non-regulatory recognition that provides external validation of the company's AI platform but does not change its clinical or financial trajectory. The filing is a routine press release with no material financial data or operational updates.
- Evaxion received the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology platform.
- The award was presented at a ceremony at the Natural History Museum in London.
- This is the second recognition from the Galien Prix Foundation in less than a year; the first was in December 2025 for Best Medical Technology / AI Advances in the Nordic and high-growth European and Middle Eastern countries.
- The jury evaluated innovation in scientific development, clinical application, utility, insights in biomedical science, and tangible impact on human health.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access